Olema Pharmaceuticals, Inc.
OLMA · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$129,474 | -$96,655 | -$104,787 | -$71,096 |
| Dep. & Amort. | $393 | $377 | $1,658 | $1,663 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $22,582 | $17,256 | $0 | $0 |
| Change in WC | $9,164 | -$589 | $3,022 | $2,830 |
| Other Non-Cash | -$7,016 | -$4,116 | $18,042 | $15,913 |
| Operating Cash Flow | -$104,351 | -$83,727 | -$82,065 | -$50,690 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$159 | $0 | -$363 | -$1,575 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | -$394,959 | -$255,625 | -$213,660 | -$486,967 |
| Inv. Sales/Matur. | $301,592 | $250,760 | $305,502 | $213,104 |
| Other Inv. Act. | $0 | $14 | $0 | $0 |
| Investing Cash Flow | -$93,526 | -$4,851 | $91,479 | -$275,438 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | $0 | $0 |
| Stock Issued | $266,288 | $129,736 | $476 | $1,391 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $2,530 | $3,679 | $0 | $0 |
| Financing Cash Flow | $268,818 | $133,415 | $476 | $1,391 |
| Forex Effect | $0 | $0 | $0 | $0 |
| Net Chg. in Cash | $70,941 | $44,837 | $9,890 | -$324,737 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $68,539 | $23,702 | $13,812 | $338,549 |
| End Cash | $139,480 | $68,539 | $23,702 | $13,812 |
| Free Cash Flow | -$104,510 | -$83,727 | -$82,428 | -$52,265 |